Health FDA Grants Breakthrough Therapy Status for Cogent’s New Cancer Treatment The U.S. Food and Drug Administration (FDA) has awarded Breakthrough Therapy Designation to Cogent Biosciences, Inc. for its innovative treatment combining bezuclastinib with sunitinib... Editorial26 January, 2026